NTT
10.6.2019 10:42:10 CEST | Business Wire | Press release
Nippon Telegraph and Telephone Corporation (TOKYO: 9432) (Head office, Chiyoda-ku, Tokyo, Japan; Jun Sawada, President & CEO; hereinafter referred to as “NTT”) has established the “Digital Twin Computing Initiative” as an innovation platform for digital transformation to meet the demands of the coming era for rapid, dynamic transformations of human societies and economies and realize smart societies [1] .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190610005259/en/
Digital Twin Computing aims to transcend the limits of conventional ICT technology by creating diversified cyberspace easily from highly precise digital information reflecting real-world objects such as things, humans and societies, to achieve not only extremely advanced and profound communications, but also achieve large-scale, high-accuracy predictions and simulations of the future. Thus, this initiative also aims to help to solve various social problems around the world, help to create innovative new services and accelerate the creation of smart societies.
The Digital Twin Computing Initiative is part of the Innovative Optical and Wireless Network (IOWN) initiative [2] promoted by NTT.
1. Background to conceptualization
NTT has continued to contribute to the achievement of the modern digital
society through its ubiquitous provision of high-speed, broadband
communications networks and safe, secure information systems. Meanwhile,
digitalization for humans from telephony through to email and social
media, and for things from maps through to digital appliances and
self-driving cars has dramatically advanced. In future, more advanced
digital societies will emerge and more closely unify the real world of
things, humans and societies and their high-precision digital
information counterparts in cyberspace.
These will be the
highly-digitalized next-generation societies in which further expansion
of human knowledge and emotional expression through large-scale,
high-accuracy predictions will be enabled by high-precision digital
information in cyberspace seamlessly linked to the real world.
Furthermore, these societies will be capable of more advanced and more
social communications (e.g. consensus building and decision-making) than
the conventional, familiar communications (e.g. knowledge sharing and
human collaboration).
To clear a path for this future society, NTT
has established the “Digital Twin Computing Initiative” as a new
information and communication initiative to undertake with its future
partners.
2. About Digital Twin Computing (Figure 1)
“Digital twins” have been mainly gaining attention in such fields as
manufacturing. A digital twin is digital information that accurately
represents features (e.g. shapes, conditions and manufacturing
processes) of things such as machine parts [3]
. Digital
information about humans such as images obtained from medical appliances
(e.g. MRI or CT scans) can also be thought of as digital twins.
In
contrast, our proposed “Digital Twin Computing (DTC)” is a computing
paradigm which expands on the above conventional digital twin concept by
enabling humans and things in the real world to be recreated and
interact without restrictions in cyberspace with "digital twin
operations” – computations to exchange, converge, replicate and
synthesize multiple digital twins.
While conventional digital twins
have been mainly used for digital observation or control of physical
objects, DTC aims to expand the scope of such digitalization from things
to humans and enhance communications among humans and things in
cyberspace.
3. The future achievable with Digital Twin Computing
DTC will enable the solutions to a variety of social problems and innovative services described below.
[Simulations at Earth and Outer Space scales] Virtual societies in cyberspace using large-scale digital twins to reproduce global-scale natural conditions (e.g. climate and reserves of resources) or social changes (e.g. populations and GDP) can be constructed to create high-accuracy prediction models for simulating and predicting the near future. These simulations and predictions can be applied to policies for sustainable development goals (SDGs), etc. based on the obtained global-scale resource balance forecasts. Moreover, combining the digital twins of real-world cities (e.g. Tokyo and San Francisco) with outer space digital twins to produce balance simulations of the atmosphere, water, food, and energy will contribute to space development.
[Discovery and resolution of urban issues] Digital twins of cities and their citizens can be used to anonymously collect the experiences, cultures, values, desires and complaints of the citizens. These digital twins can be used to discover latent problems in cities that usually go unnoticed such as dangerous intersections and high accident rate areas, and find solutions optimized for collectives. Also, these digital twins can be used to simulate synergies with other cities and generate “sister cities” with similarities or mutually complementary and unexpected combinations leading to new collaborative relationships for building wealthier cities.
[Prediction and control of diseases] To combat the outbreak of an infectious disease, virtual societies can be created in cyberspace by combining geographical and transport information, etc. with digital twins of people mapping their activity and relationship patterns to accurately make predictions of the spread of the infection and enable real-time active control of the outbreak by controlling the flows of transport and humans, making decisions about class closures in schools or remote learning, and by enabling automatic search and reservation of the most appropriate hospitals.
[Multifaceted personal decision-making] Recording your work skills into a digital twin will allow you to have the digital twin perform daily tasks such as scheduling or making bookings for meeting rooms. In addition, your digital twin could be replicated so that you can alter the digital version of your past self, various situations or pre-supposed knowledge and engage in dialogue between your real-world self and your altered digital twin to attempt to uncover solutions to various problems. Moreover, a number of your digital twins could debate at super high-speed in cyberspace to discover solutions or perspectives that you might not be able to see.
4. The platform driving Digital Twin Computing (Figure 2)
The DTC platform consists of the following four layers; the
“Cyber/physical interaction layer”, a layer to collect the
physical-world data required to generate a digital twin, and to submit
feedback to the physical-world from the application running on the
platform; the “Digital twin layer”, a layer to generate and maintain
digital twins using data received from the Cyber/physical interaction
layer; the “Digital world presentation layer”, a layer to provide the
framework to invoke digital twin operations using digital twins stored
in the Digital twin layer; and the “Application layer”, a layer to
easily create DTC applications using the digital world presentation
layer.
As a crucial aspect of this achievement, the privacy of
humans and the intentions of the owners of things must be fully
respected and information related to them must be handled with all the
necessary care. Thus, this platform must be equipped with security
mechanisms to preserve privacy.
5. Going forward
The success of the Digital Twin Computing Initiative will depend on intimate cooperation across wide-ranging fields of research and technology such as the social sciences, the humanities, natural and applied sciences and interdisciplinary fields. NTT Laboratories aim to achieve the Digital Twin Computing Initiative by collaborating with future professionals and global partners across these wide-ranging fields of research and technology. For details about this Initiative, please refer to the white paper at http://www.ntt.co.jp/svlab/e/DTC/whitepaper.html .
[1] NTT Group Mid-term Management Strategy “Your Value Partner 2025” (in
Japanese)
[2] Innovative Optical and Wireless Network (IOWN)
[3]
Dr. Michael Grieves, Digital Twin: Manufacturing Excellence through
Virtual Factory Replication, 2015
View source version on businesswire.com: https://www.businesswire.com/news/home/20190610005259/en/
Contact:
Inquiries regarding this press release: Nippon Telegraph and Telephone Corporation Research and Development Planning Department iown-pr@hco.ntt.co.jp
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
